XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Share Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Activity with Respect to, and Status of, RSUs
A summary of the activity with respect to, and status of, RSUs during the three and nine-month period ended September 30, 2024 is presented below:
Number of
 RSUs
Weighted
 Average Grant
 Date Value
Unvested as of January 1, 20241,655,542$9.61 
Granted2,276,7108.10 
Forfeited(108,000)10.12 
Vested(638,629)6.91 
Unvested as of March 31, 20243,185,623$8.93 
Granted490,1403.48 
Forfeited(5,000)10.12 
Vested(642,204)6.44 
Unvested as of June 30, 20243,028,559$6.65 
Granted150,0002.71 
Forfeited(133,981)7.01 
Vested(609,336)6.02 
Unvested as of September 30, 20242,435,242$6.64 
Schedule of Common Stock and Current Interest Rates The fair value of the earn-out shares was estimated using a Monte Carlo simulation utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Common Stock and current interest rates. Below are the key assumptions used in valuing the earn-out shares:
As of
7/19/2023
PSQH Stock Price$9.08 
Volatility40.0 %
Risk free rate of return4.6 %
Expected term (in years)4.8 years
Schedule of Share-Based Compensation Expense
During the three and nine months ended September 30, 2024, the Company recorded the following share-based compensation expense, related to RSUs, earn-out shares and Credova Merger:
 For the
three months
ended
September 30,
2024
For the
nine months
ended
September 30,
2024
Cost of sales$28,407 $108,392 
General and administrative expenses4,092,365 9,948,361 
Research and development411,470 1,149,456 
Sales and marketing1,264,581 4,761,388 
Transaction costs incurred in connection with Credova Merger— 887,409 
 $5,796,823 $16,855,006 
During the three and nine months ended September 30, 2023, the Company recorded the following share-based compensation expense, related to RSUs and earn-out shares:
For the
three and nine
months ended
September 30,
2023
Cost of sales$2,239 
General and administrative expenses587,717 
Research and development201,810 
Sales and marketing393,323 
Transaction incurred in connection with the Business Combination910,800 
 $2,095,889